Hair loss is not a recognized side effect of fenofibrate. It does not appear in the FDA-approved prescribing information for the drug, and clinical trial data spanning thousands of patients have not identified alopecia as a reportable adverse reaction. That said, dermatologic side effects do occur at low rates, and individual reports of hair thinning while taking lipid-lowering medications exist across the drug class.
What Clinical Trials Actually Show
In double-blind, placebo-controlled trials submitted to the FDA, the side effects reported at meaningful rates were liver function changes (8% vs. 1% for placebo), abdominal pain, elevated muscle enzymes, constipation, and nasal inflammation. Skin-related reactions like hives occurred in about 1.1% of fenofibrate patients compared to 1% on placebo, and rash in 1.4% versus 0.8%. Hair loss was not among the adverse reactions tracked or reported.
Longer-term safety data from over 1,500 patients taking fenofibrate for more than six months found skin problems in only 0.2% of users. In two separate U.S. lipid studies, dermatologic reactions were slightly more common with fenofibrate than placebo (13 vs. 1 in one study, 3 vs. 0 in another), but these were categorized broadly as “dermatologic” without specifying hair loss. The post-marketing surveillance section of the prescribing information, which captures rare side effects reported after the drug reaches the public, lists photosensitivity reactions but not alopecia.
The Fibrate Class and Hair Loss
Fenofibrate belongs to a family of drugs called fibrates. An older drug in this class, clofibrate, does list alopecia among its known side effects alongside gastrointestinal upset, weakness, drowsiness, and skin rash. This connection to a related medication may be one reason people wonder whether fenofibrate carries the same risk. However, fenofibrate and clofibrate have different side effect profiles, and the hair loss seen with clofibrate has not carried over to fenofibrate in clinical evidence.
Why You Might Still Notice Hair Changes
If you’re experiencing hair thinning while taking fenofibrate, there are several possible explanations beyond the medication itself. Cholesterol-lowering drugs as a group, including statins, have occasional anecdotal reports of hair shedding, though the rates are generally very low and establishing a direct cause is difficult. Hair follicles cycle through growth and resting phases over months, so pinpointing the trigger for increased shedding can be tricky.
A more common culprit is telogen effluvium, a temporary form of diffuse hair shedding triggered by physical stress, illness, significant weight changes, nutritional deficiencies, or hormonal shifts. If you started fenofibrate around the same time as a dietary change, a new exercise routine, or another medication, any of those could be contributing. Thyroid dysfunction, iron deficiency, and hormonal changes are also well-established causes of hair thinning that may coincidentally overlap with starting a new prescription.
What to Do if You Notice Hair Thinning
Since fenofibrate lacks a documented link to hair loss, stopping the medication on your own is not a good trade-off given the cardiovascular benefits it provides. If hair shedding started within a few weeks to a few months of beginning fenofibrate, it’s worth mentioning to your prescriber. They can evaluate whether another factor is responsible and check for common causes like thyroid problems or nutrient deficiencies with simple blood work.
If fenofibrate is genuinely suspected, a prescriber may consider a temporary pause to see if shedding resolves, then potentially restart it to confirm the pattern. Drug-induced hair loss is almost always reversible once the triggering medication is removed, with regrowth typically beginning within three to six months.